Clinical Trial Update: Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

View source ↗

Summary

A completed observational study by Janssen Korea evaluated the response rate of itraconazole injection in immunocompromised patients with hematologic malignanci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Neutropenia

Drugs mentioned

• Itraconazole injection (Itraconazole)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Hematological Malignancies, Neutropenia | Status: COMPLETED